This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: David N Johnson: Innovator in Pharmaceutical Compounds
Introduction
David N Johnson is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various medical conditions. His work has the potential to impact the treatment of numerous inflammatory and autoimmune diseases.
Latest Patents
David N Johnson holds a patent for "Substituted heterocyclic compounds and methods of use." This invention relates to pyrimidine or pyridine carboxamides or pharmaceutically-acceptable salts thereof. The patent outlines a method for treating inflammation and inhibiting T cell activation and proliferation. It addresses a wide range of conditions, including arthritis, multiple sclerosis, and various allergic diseases. The therapeutic applications of his invention are extensive, making it a valuable contribution to medical science.
Career Highlights
Throughout his career, David has been associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to collaborate with other talented professionals in the field. His innovative approach to drug development has positioned him as a key figure in pharmaceutical research.
Collaborations
David has worked alongside notable colleagues such as Joseph J Nunes and Eoin Christopher Power. These collaborations have fostered an environment of innovation and have contributed to the advancement of their shared goals in pharmaceutical research.
Conclusion
David N Johnson's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in the treatment of various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
